Solid Biosciences (SLDB) Competitors $5.12 -0.32 (-5.88%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$5.14 +0.02 (+0.39%) As of 09/19/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLDB vs. VCEL, AUPH, CDTX, ARDX, TWST, VERA, EWTX, AVDL, JANX, and HROWShould you be buying Solid Biosciences stock or one of its competitors? The main competitors of Solid Biosciences include Vericel (VCEL), Aurinia Pharmaceuticals (AUPH), Cidara Therapeutics (CDTX), Ardelyx (ARDX), Twist Bioscience (TWST), Vera Therapeutics (VERA), Edgewise Therapeutics (EWTX), Avadel Pharmaceuticals (AVDL), Janux Therapeutics (JANX), and Harrow (HROW). These companies are all part of the "pharmaceutical products" industry. Solid Biosciences vs. Its Competitors Vericel Aurinia Pharmaceuticals Cidara Therapeutics Ardelyx Twist Bioscience Vera Therapeutics Edgewise Therapeutics Avadel Pharmaceuticals Janux Therapeutics Harrow Solid Biosciences (NASDAQ:SLDB) and Vericel (NASDAQ:VCEL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment. Which has more volatility and risk, SLDB or VCEL? Solid Biosciences has a beta of 2.54, meaning that its stock price is 154% more volatile than the S&P 500. Comparatively, Vericel has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Does the media prefer SLDB or VCEL? In the previous week, Vericel had 12 more articles in the media than Solid Biosciences. MarketBeat recorded 14 mentions for Vericel and 2 mentions for Solid Biosciences. Solid Biosciences' average media sentiment score of 0.75 beat Vericel's score of 0.13 indicating that Solid Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solid Biosciences 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vericel 4 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 1 Very Negative mention(s) Neutral Is SLDB or VCEL more profitable? Vericel has a net margin of 2.85% compared to Solid Biosciences' net margin of 0.00%. Vericel's return on equity of 2.47% beat Solid Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Solid BiosciencesN/A -69.70% -56.74% Vericel 2.85%2.47%1.69% Do institutionals and insiders have more ownership in SLDB or VCEL? 81.5% of Solid Biosciences shares are owned by institutional investors. 1.9% of Solid Biosciences shares are owned by insiders. Comparatively, 5.2% of Vericel shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts recommend SLDB or VCEL? Solid Biosciences presently has a consensus price target of $15.00, indicating a potential upside of 192.97%. Vericel has a consensus price target of $60.40, indicating a potential upside of 90.66%. Given Solid Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Solid Biosciences is more favorable than Vericel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solid Biosciences 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Vericel 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has higher earnings and valuation, SLDB or VCEL? Vericel has higher revenue and earnings than Solid Biosciences. Solid Biosciences is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSolid Biosciences$8.09M49.28-$124.70M-$2.80-1.83Vericel$249.12M6.42$10.36M$0.12264.00 SummaryVericel beats Solid Biosciences on 9 of the 17 factors compared between the two stocks. Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SLDB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLDB vs. The Competition Export to ExcelMetricSolid BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$398.69M$3.14B$5.78B$10.46BDividend YieldN/A2.35%5.61%4.61%P/E Ratio-1.8320.9180.5026.81Price / Sales49.28416.22503.13112.35Price / CashN/A46.4637.6661.43Price / Book1.499.6015.756.39Net Income-$124.70M-$53.22M$3.30B$271.80M7 Day Performance-5.01%3.11%5.35%3.49%1 Month Performance-9.54%7.56%8.09%9.90%1 Year Performance-34.86%11.15%81.33%28.62% Solid Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLDBSolid Biosciences2.7093 of 5 stars$5.12-5.9%$15.00+193.0%-36.0%$398.69M$8.09M-1.83100High Trading VolumeVCELVericel2.8419 of 5 stars$32.93+5.2%$60.40+83.4%-34.0%$1.63B$237.22M269.61300News CoverageAnalyst DowngradeGap UpAUPHAurinia Pharmaceuticals2.4963 of 5 stars$12.40+1.4%$12.00-3.2%+80.6%$1.63B$235.13M28.83300CDTXCidara Therapeutics3.0472 of 5 stars$63.95+0.8%$64.14+0.3%+486.3%$1.61B$1.27M-5.7090ARDXArdelyx4.3858 of 5 stars$6.64-0.1%$11.70+76.3%+3.7%$1.60B$333.61M-28.8590Positive NewsTWSTTwist Bioscience3.882 of 5 stars$25.84+7.0%$49.40+91.2%-41.9%$1.56B$312.97M-17.81990VERAVera Therapeutics3.0216 of 5 stars$24.31-0.2%$63.00+159.2%-39.1%$1.55BN/A-6.7940Positive NewsAnalyst ForecastEWTXEdgewise Therapeutics2.5235 of 5 stars$14.62-0.4%$40.55+177.4%-51.7%$1.54BN/A-9.4360AVDLAvadel Pharmaceuticals2.8223 of 5 stars$15.47-2.2%$20.86+34.8%+19.1%$1.50B$169.12M-515.6770Positive NewsAnalyst DowngradeJANXJanux Therapeutics2.5661 of 5 stars$24.62+1.3%$80.92+228.7%-53.1%$1.48B$10.59M-13.6530Analyst ForecastHROWHarrow2.8133 of 5 stars$39.84+2.5%$64.67+62.3%-4.6%$1.47B$199.61M-159.30180 Related Companies and Tools Related Companies Vericel Competitors Aurinia Pharmaceuticals Competitors Cidara Therapeutics Competitors Ardelyx Competitors Twist Bioscience Competitors Vera Therapeutics Competitors Edgewise Therapeutics Competitors Avadel Pharmaceuticals Competitors Janux Therapeutics Competitors Harrow Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLDB) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLDB Stock Alerts